Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for pain control after rotator cuff repair or shoulder decompression surgery
ACTRN12615001175561Phase 3Not yet recruiting
- Sponsor
- Epworth HealthCare
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pregabalin in rotator cuff tear and rotator cuff tendinitis, sponsored by Epworth HealthCare. Primary endpoint: Average rest pain at 2 weeks post-operation. Planned start Nov 2015; status: not yet recruiting.
02
Drugs
pregabalin
03
Conditions
rotator cuff tearrotator cuff tendinitis
Beyond the preview
Go deeper on ACTRN12615001175561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615001175561.